Advertisement
Product › Details
TALEN® technology (Transcription Activator-Like Effector Nuclease)
Next higher product group | nucleic acid editing technology (DNA/RNA-editing technology) | |
Status | 2011-02-28 sales existent | |
Organisation | Cellectis Bioresearch SAS | |
Original research | University of Halle (Martin-Luther Universität Halle-Wittenberg) | |
Record changed: 2023-07-10 |
Advertisement
More documents for nucleic acid editing technology (DNA/RNA-editing technology)
- [1] ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin....
- [2] ERS Genomics Ltd.. (3/13/24). "Press Release: Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Tokyo & Dublin....
- [3] CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA....
- [4] Laverock Therapeutics Ltd.. (9/28/23). "Press Release: Laverock Therapeutics Raises £13.5M to Develop Unique Gene Silencing Platform for Programmable Advanced Therapies"....
- [5] Alia Therapeutics S.r.l.. (5/5/23). "Press Release: Alia Therapeutics Names Letizia Goretti as Chief Executive Officer". Milan....
- [6] Synthego Corporation. (3/16/23). "Press Release: Synthego Introduces CRISPR Discovery Partners to Streamline CRISPR-Driven Drug Discovery Research". Redwood City, CA....
- [7] Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge....
- [8] LogicBio Therapeutics, Inc.. (10/3/22). "Press Release: Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics to Accelerate Growth in Genomic Medicine". Lexington, MA....
- [9] Laverock Therapeutics Ltd.. (8/31/22). "Press Release: Laverock Therapeutics Founded to Develop the Next Generation of Programmable Cell Therapies"....
- [10] Replay Holdings LLC. (7/25/22). "Press Release: Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA". San Diego, CA & London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top